Phase I/II clinical trial of D1-AAT, which includes the Alpha 1 protein, for the treatment of Type 1 diabetes (juvenile diabetes). The trial found stabilization and even improvement in diabetes measures of the patients, and a high safety profile in the 20 children and adolescents tested.
FULL ARTICLE AT Globes Online